---
document_datetime: 2025-02-12 09:57:28
document_pages: 7
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/pemetrexed-accord-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: pemetrexed-accord-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 4.6889468
conversion_datetime: 2025-12-27 19:58:30.373374
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Pemetrexed Accord

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                   |
|----------------------|----------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/2330/ 202402   | Periodic Safety Update EU Single assessment - pemetrexed                                     | 17/10/2024                          | 12/12/2024                                  | SmPC and PL                      | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/2330/202402. |
| IAIN/0031/G          | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a | 20/09/2024                          | 12/12/2024                                  | Annex II and PL                  |                                                                                                                                           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           | manufacturing site for the FP - Secondary packaging site B.II.b.2.c.2 - Change to importer, batch release arrangements and quality control testing of the FP - Including batch control/testing                                                                                                                                                                                                                                                                                                                                                                                                                     |            |            |                 |                 |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|-----------------|
| II/0028   | B.II.b.4.d - Change in the batch size (including batch size ranges) of the finished product - The change relates to all other pharmaceutical forms manufactured by complex manufacturing processes                                                                                                                                                                                                                                                                                                                                                                                                                 | 18/07/2024 | n/a        |                 |                 |
| IB/0027/G | This was an application for a group of variations. B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.III.1.a.5 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate of a non-sterile AS that is to be used in a sterile medicinal product, where water is used in the last steps of the synthesis and the material is not claimed free | 07/02/2024 | n/a        |                 | to be endotoxin |
| N/0029    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 25/01/2024 | 09/10/2024 | PL              |                 |
| IA/0026/G | This was an application for a group of variations. A.5.b - Administrative change - Change in the name                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 13/10/2023 | 09/10/2024 | Annex II and PL |                 |

<div style=\"page-break-after: always\"></div>

|         | and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) A.7 - Administrative change - Deletion of manufacturing sites B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                                                         |            |     |           |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------|
| II/0025 | B.II.b.4.d - Change in the batch size (including batch size ranges) of the finished product - The change relates to all other pharmaceutical forms manufactured by complex manufacturing processes                                                                                                                                                                                                                                                                                             | 28/09/2023 | n/a |           |
|         | This was an application for a group of variations. B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method | 07/07/2023 | n/a | IA/0024/G |
| IA/0023 | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                                                                                                                                                                                                                                                               | 17/02/2023 | n/a |           |

<div style=\"page-break-after: always\"></div>

| II/0020            | B.II.b.4.d - Change in the batch size (including batch size ranges) of the finished product - The change relates to all other pharmaceutical forms manufactured by complex manufacturing processes                                                           | 13/10/2022   | n/a        |                 |                                                                                                                                                                                                                                                                             |
|--------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0022            | B.II.e.2.a - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Tightening of specification limits                                                                                                    | 30/09/2022   | n/a        |                 |                                                                                                                                                                                                                                                                             |
| IB/0021            | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 23/08/2022   | 03/02/2023 | SmPC and PL     | Sections 4.4 and 4.6 of the SmPC have been updated concerning duration of contraception following the end of treatment with a genotoxic drug, following assessment of the same changes adopted for the reference product. The package leaflet has been updated accordingly. |
| IB/0019            | B.II.d.1.z - Change in the specification parameters and/or limits of the finished product - Other variation                                                                                                                                                  | 23/05/2022   | n/a        |                 |                                                                                                                                                                                                                                                                             |
| IA/0018            | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                | 17/01/2022   | 03/02/2023 | Annex II and PL |                                                                                                                                                                                                                                                                             |
| PSUSA/2330/ 202102 | Periodic Safety Update EU Single assessment - pemetrexed                                                                                                                                                                                                     | 30/09/2021   | n/a        |                 | PRAC Recommendation - maintenance                                                                                                                                                                                                                                           |
| IB/0017            | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 29/07/2021   | 27/01/2022 | PL              |                                                                                                                                                                                                                                                                             |

<div style=\"page-break-after: always\"></div>

| IB/0015   | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                         | 04/06/2021   | n/a        |                                  |                                                                                                                                                                                                                                                                                 |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0014   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 07/01/2021   | 27/01/2022 | SmPC and PL                      |                                                                                                                                                                                                                                                                                 |
| X/0010    | Annex I_2.(c) Change or addition of a new strength/potency Annex I_2.(d) Change or addition of a new pharmaceutical form                                                                                                                                     | 17/09/2020   | 16/11/2020 | SmPC, Labelling and PL           |                                                                                                                                                                                                                                                                                 |
| R/0012    | Renewal of the marketing authorisation.                                                                                                                                                                                                                      | 23/07/2020   | 09/10/2020 | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Pemetrexed Accord in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| IB/0013   | B.II.b.4.z - Change in the batch size (including batch size ranges) of the finished product - Other variation                                                                                                                                                | 14/08/2020   | n/a        |                                  |                                                                                                                                                                                                                                                                                 |
| IB/0011   | B.II.b.4.z - Change in the batch size (including batch size ranges) of the finished product - Other variation                                                                                                                                                | 06/05/2020   | n/a        |                                  |                                                                                                                                                                                                                                                                                 |
| IB/0009   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference                                                                                                               | 28/05/2019   | 28/02/2020 | SmPC and PL                      |                                                                                                                                                                                                                                                                                 |

<div style=\"page-break-after: always\"></div>

|             | - Implementation of change(s) for which NO additional data is required to be submitted by MAH                                                                                                                                                                                                                                                                                  |            |            |                        | product new the   |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-------------------|
| IA/0008     | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                                                                                                                                                     | 04/03/2019 | n/a        |                        |                   |
| IAIN/0007/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - batch control/testing | 04/03/2019 | 28/02/2020 | Annex II and PL        | Not including     |
| T/0006      | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                            | 28/01/2019 | 25/02/2019 | SmPC, Labelling and PL |                   |
| IB/0005     | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                 | 20/04/2018 | 25/02/2019 | SmPC and PL            |                   |
| IB/0004     | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO data is required to be submitted by                                                                                                                                          | 30/05/2017 | 07/06/2018 | SmPC, Labelling and PL | new additional    |

<div style=\"page-break-after: always\"></div>

|         | the MAH                                                                                                                                                                                          |            |     |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IA/0003 | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) | 14/09/2016 | n/a |
| IA/0002 | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                     | 03/08/2016 | n/a |
| IA/0001 | B.II.e.3.b - Change in test procedure for the immediate packaging of the finished product - Other changes to a test procedure (including replacement or addition)                                | 22/03/2016 | n/a |